SIGNIFICANCE OF RELAPSE FOLLOWING ADJUVANT THERAPY WITH CMF OR 5-FU IN HIGH-RISK BREAST-CANCER

被引：0
|
作者：
CHLEBOWSKI, RT [1 ]
WEINER, JM [1 ]
LUCE, J [1 ]
HESTORFF, R [1 ]
LANG, JE [1 ]
REYNOLDS, R [1 ]
GODFREY, T [1 ]
RYDEN, VMJ [1 ]
BATEMAN, JR [1 ]
机构：
[1] WESTERN CANC STUDY GRP,LOS ANGELES,CA 90509
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [1] LONG-TERM SURVIVAL FOLLOWING RELAPSE AFTER 5-FU BUT NOT CMF ADJUVANT BREAST-CANCER THERAPY
    CHLEBOWSKI, RT
    WEINER, JM
    REYNOLDS, R
    LUCE, J
    BULCAVAGE, L
    BATEMAN, JR
    BREAST CANCER RESEARCH AND TREATMENT, 1986, 7 (01) : 23 - 29
  • [2] PROLONGED SURVIVAL (SALVAGE) FOLLOWING RELAPSE ON SINGLE AGENT 5-FU BUT NOT CMF ADJUVANT BREAST-CANCER THERAPY
    CHLEBOWSKI, RT
    WEINER, JM
    REYNOLDS, R
    LUCE, J
    LANG, J
    HESTORFF, R
    GODFREY, T
    BATEMAN, JR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 174 - 174
  • [3] PROLONGED SURVIVAL FOLLOWING RELAPSE AFTER 5-FU BUT NOT CMF ADJUVANT BREAST-CANCER THERAPY - RESULTS AT 9 YEARS
    CHLEBOWSKI, RT
    WEINER, JM
    REYNOLDS, R
    LUCE, J
    LANG, J
    HESTORFF, R
    GODFREY, T
    BATEMAN, JR
    BREAST CANCER RESEARCH AND TREATMENT, 1984, 4 (04) : 335 - 335
  • [4] 5-FU AS AN ADJUVANT TO MASTECTOMY IN HIGH-RISK PATIENTS
    ANSFIELD, FJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 177 - 177
  • [5] ADJUVANT SYSTEMIC THERAPY IN WOMEN WITH EARLY-STAGE BREAST-CANCER AT HIGH-RISK FOR RELAPSE
    DAVIDSON, NE
    ABELOFF, MD
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (05) : 301 - 305
  • [6] SEQUENTIAL METHOTREXATE AND 5-FU IN CMFP (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FU, AND PREDNISONE) THERAPY FOR BREAST-CANCER
    CADMAN, EC
    GLICK, JH
    CROSS, J
    HORTON, J
    TAYLOR, SG
    CANCER TREATMENT REPORTS, 1984, 68 (06): : 877 - 879
  • [7] ADJUVANT SYSTEMIC THERAPY IN HIGH-RISK BREAST-CANCER - THE DANISH BREAST-CANCER COOPERATIVE GROUPS TRIALS OF CYCLOPHOSPHAMIDE OR CMF IN PREMENOPAUSAL AND TAMOXIFEN IN POSTMENOPAUSAL PATIENTS
    MOURIDSEN, HT
    ROSE, C
    BRINCKER, H
    THORPE, SM
    RANK, F
    FISCHERMAN, K
    ANDERSEN, KW
    RECENT RESULTS IN CANCER RESEARCH, 1984, 96 : 117 - 128
  • [8] MITOXANTRONE, 5-FU, AND LEUCOVORIN IN BREAST-CANCER
    SWAIN, SM
    HONIG, SF
    MEDICAL AND PEDIATRIC ONCOLOGY, 1994, 22 (06): : 370 - 374
  • [9] ADJUVANT 5 FU-IRRADIATION-5 FU FOLLOWING MASTECTOMY IN HIGH-RISK PATIENTS
    RAMIREZ, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 49 - 49
  • [10] Adjuvant 5-FU based therapy for colorectal cancer
    Muñoz, A
    Rubio, I
    Mañé, JM
    Barceló, JR
    Fernández, R
    Abón, G
    Fuente, N
    López-Vivanco, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S78
12345